Wound Care - Lebanon

  • Lebanon
  • Revenue in the Wound Care market amounts to US$1.26m in 2024. The market is expected to grow annually by -3.04% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.24 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Lebanon has been experiencing significant growth in recent years. Customer preferences have shifted towards advanced wound care products and treatments, leading to an increased demand for these products in the market.

Customer preferences:
Lebanese customers have shown a growing preference for advanced wound care products and treatments. This can be attributed to several factors, including increasing awareness about the importance of proper wound care and the availability of innovative products in the market. Customers are seeking products that promote faster healing, reduce the risk of infection, and provide better overall wound management. As a result, there has been a rising demand for products such as wound dressings, wound closure devices, and antimicrobial agents.

Trends in the market:
One of the key trends in the Wound Care market in Lebanon is the adoption of advanced wound care technologies. Healthcare professionals are increasingly using products such as hydrogels, foam dressings, and negative pressure wound therapy to treat complex wounds. These advanced technologies offer benefits such as improved wound healing, reduced pain, and enhanced patient comfort. Additionally, there is a growing trend towards the use of bioactive dressings and tissue-engineered products, which promote tissue regeneration and accelerate the healing process.

Local special circumstances:
Lebanon has a high prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, due to factors such as an aging population and an increase in chronic diseases. This has created a significant demand for wound care products and treatments in the country. Additionally, Lebanon has a well-developed healthcare infrastructure, with a strong network of hospitals and clinics. This allows for easy access to wound care products and services, further driving market growth.

Underlying macroeconomic factors:
Lebanon has a stable economy with a relatively high GDP per capita compared to other countries in the region. This has resulted in increased healthcare spending, including spending on wound care products and treatments. Additionally, the government has taken steps to improve healthcare access and quality, which has further contributed to the growth of the Wound Care market in Lebanon. The country also benefits from a well-educated healthcare workforce, which plays a crucial role in driving market development and innovation. In conclusion, the Wound Care market in Lebanon is experiencing growth due to customer preferences for advanced wound care products and treatments. The adoption of advanced wound care technologies, high prevalence of chronic wounds, and favorable macroeconomic factors are all contributing to the market's development. As the demand for wound care products continues to rise, it is expected that the market will further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)